These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 102999)

  • 21. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).
    Carson DA; Kaye J; Seegmiller JE
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5677-81. PubMed ID: 202960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase: overview, genetic heterogeneity and therapy.
    Hirschhorn R
    Birth Defects Orig Artic Ser; 1983; 19(3):73-81. PubMed ID: 6418227
    [No Abstract]   [Full Text] [Related]  

  • 23. Inherited immunodeficiency diseases: relationship to lymphocyte metabolic dysfunction.
    Giblett ER; Polmar SH
    Prog Med Genet; 1979; 3():177-219. PubMed ID: 118484
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immune insufficiency in enzyme defects of purine metabolism].
    Müller G
    Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deoxyguanosine toxicity in a mouse T lymphoma: relationship to purine nucleoside phosphorylase-associated immune dysfunction.
    Gudas LJ; Ullman B; Cohen A; Martin DW
    Cell; 1978 Jul; 14(3):531-8. PubMed ID: 99243
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical basis for lymphocyte dysfunction in adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Adv Exp Med Biol; 1984; 165 Pt B():133-9. PubMed ID: 6426261
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Shanon A; Levin S; Holtzman F; Brock-Sinai F; Abu-Said A
    Arch Dis Child; 1988 Aug; 63(8):931-4. PubMed ID: 3137899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.
    Ullman B; Cohen A; Martin DW
    Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of oroticaciduria in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Potter CF; Sahota A; Cameron JS; Webster DR; Becroft DM
    Clin Exp Immunol; 1978 Oct; 34(1):42-5. PubMed ID: 108039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Molecular pathology of immunological deficiency. Apropos of adenosine deaminase deficiency and nucleoside phosphorylase deficiency].
    Souillet G
    Pediatrie; 1975; 30(7):746-56. PubMed ID: 1105387
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immune deficiencies secondary to enzymopathies].
    Pérignon JL; Hamet M
    Ann Pediatr (Paris); 1989 Jun; 36(6):381-5. PubMed ID: 2502942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 34. Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.
    Mitchell BS; Kelley WN
    Ann Intern Med; 1980 Jun; 92(6):826-31. PubMed ID: 6247948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological aspects of purine metabolism.
    Seegmiller JE; Watanabe T; Shreier MH; Waldmann TA
    Adv Exp Med Biol; 1977; 76A():412-33. PubMed ID: 193375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purine metabolism in cultured human fibroblasts derived from patients deficient in hypoxanthine phosphoribosyltransferase, purine nucleoside phosphorylase, or adenosine deaminase.
    Thompson LF; Willis RC; Stoop JW; Seegmiller JE
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3722-6. PubMed ID: 99741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 40. Ecto-5'-nucleotidase deficiency: association with adenosine deaminase deficiency and nonassociation with deoxyadenosine toxicity.
    Boss GR; Thompson LF; O'Connor RD; Ziering RW; Seegmiller JE
    Clin Immunol Immunopathol; 1981 Apr; 19(1):1-7. PubMed ID: 6260402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.